Literature DB >> 15364726

Vitreous opacities and retinal vascular abnormalities in Gaucher disease.

Eric M Shrier1, Charles C Barr, Gregory A Grabowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15364726     DOI： 10.1001/archopht.122.9.1395

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  13 in total

Review 1.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

2.  Photo Essay: Retinal Changes in Type 3 Gaucher Disease.

Authors:  Shweta Anand; Desmond Kidd; Derralynn Hughes
Journal:  Neuroophthalmology       Date:  2018-02-05

3.  Retinal detachment in a boy with Gaucher disease.

Authors:  Tan-Tai Zhao; Hui-Ling Li; Xiao-Jian Guo; Jing Luo; Xiao Liu; Fang Fang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

Review 4.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

5.  Functional retinal changes in Gaucher disease.

Authors:  Seid-Fatima Seidova; Konstantin Kotliar; Frauke Foerger; Matthias Klopfer; Ines Lanzl
Journal:  Doc Ophthalmol       Date:  2008-09-06       Impact factor: 2.379

Review 6.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

7.  Ocular signs correlate well with disease severity and genotype in Fabry disease.

Authors:  Susanne Pitz; Gisela Kalkum; Laila Arash; Nesrin Karabul; Andrea Sodi; Sylvain Larroque; Michael Beck; Andreas Gal
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

8.  Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment.

Authors:  Aizeddin Mhanni; Michel Boutin; Frank Stockl; Janine Johnston; Jeff Barnes; Donald Duerksen; Leanne Zimmer; Christiane Auray-Blais; Cheryl Rockman-Greenberg
Journal:  Diagnostics (Basel)       Date:  2020-01-26

9.  Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.

Authors:  Alisdair McNeill; Gloria Roberti; Gerassimos Lascaratos; Derralynn Hughes; Atul Mehta; David F Garway-Heath; Anthony H V Schapira
Journal:  Mol Genet Metab       Date:  2013-04-10       Impact factor: 4.797

10.  The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.

Authors:  Nadia Sawicka-Gutaj; Maciej Machaczka; Izabela Kulińska-Niedziela; Jadwiga Bernardczyk-Meller; Paweł Gutaj; Jerzy Sowiński; Marek Ruchała
Journal:  Ups J Med Sci       Date:  2016-04-11       Impact factor: 2.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.